IDS moves into Chinese Diagnostics Market

Immunodiagnostic Systems (IDS) a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has appointed Beijing Leadman Biochemistry Technology Co as its exclusive distributor for the IDS-iSYS instrument and assays in the People’s Republic of China. The two partners have also agreed on the planned conversion of over 50 of Leadman’s proprietary immunoassays for use on the IDS-iSYS instrument.

Established in 1997 Leadman, a leading developer, manufacturer and distributor of in vitro diagnostic products in China, is headquartered in the Beijing Economic-Technological Development Area where it operates its R&D centre and reference laboratory. Leadman’s sales network covers 28 provinces in China, with 8 regional sales offices and over 2,000 customers.

The 3 year distribution agreement will commence from the date of the China Food and Drug Administration (CFDA) approval of the IDS-iSYS instrument and the first IDS assay anticipated to take around  12-14 months.

Under the agreement terms over 300 IDS-iSYS instruments could be placed by Leadman and its sub-distributors in the Chinese market during the 3 year period, reports IDS.